MISSISSAUGA, ON, Sept. 8, 2017 /CNW/ - MyndTec, an award-winning Canadian medical technology company announced today it has received 510(k) clearance to market its landmark product MyndMove®. MyndTec is a pioneer in the treatment of arm and hand paralysis caused by stroke or spinal cord injury.
"This is a major milestone in the evolution of our company," said MyndTec Founder Dr. Milos R. Popovic. "We are delighted that we can now offer this life-changing therapy to patients in the U.S. with upper extremity paralysis."
MyndTec intends to initiate a pilot launch of MyndMove® into the U.S. market which complements a product introduction already underway in Canada with a previously announced approval from Health Canada.
MyndMove® Therapy is a functional electric stimulation (FES) based...Read More